Introduction 61 62
Alcohol drinking is a major dose-dependent contributor to morbidity and mortality. Globally, 3 63 million annual deaths (5 % of all deaths) result from alcohol consumption, and is also linked to more 64 than 200 disease and injury outcomes. (1) As ethanol is a psychoactive substance with addictive 65
properties,(2) alcohol consumption can lead to the development of alcohol use disorders (AUDs), 66 globally prevalent mental disorders of pathological addictive or abusive drinking patterns, which are 67 linked to worse health outcomes, negative socioeconomic effects, and increased mortality.(3) There 68 is a strong connection between the health burden and the level of alcohol consumed, (4) and in 69 total alcohol has been estimated to be the most damaging of all substances of abuse, in terms of 70 harm caused to self and others.(5) 71 72 Alcohol-related behaviors are also affected by genetic factors and the estimated heritability of 73 alcohol consumption in twin studies has ranged between 35% and 65% (weighted average 37%) (6) 74 and its single nucleotide polymorphism -based heritability has been estimated to be 10%. Polygenic risk scores (PRS) derived from GWAS summary statistics have showcased improved 82 performance in disease prediction. (11) PRSs for known risk factors have also been shown to 83 associate with the related disease (12) and recently associations between multiple risk factor PRSs 84 and related traits were confirmed and reported. (13, 14) However, the link between PRSs for 85 behavioral traits and associated health outcomes remains poorly understood. 86 cohorts (n=96,499) linked to electronic health records. Furthermore, we studied whether the PRS 92 for alcohol consumption predicts alcohol-related outcomes beyond self-reported alcohol 93 consumption and other related risk factors, thus providing more objective information independent 94 of individual reporting bias or temporal fluctuations. 95 96
Materials and methods

98
Study sample and definition of alcohol-related morbidity 99
The data is comprised of 96,499 Finnish individuals from FinnGen Data Freeze 2, which includes 100 prospective epidemiological and disease-based cohorts as well as hospital biobank samples 101 (Supplementary Table 1 
Alcohol consumption 201 202
In a meta-analysis of the three cohorts with alcohol consumption estimates available (n=39,888), 203 the PRS for alcohol consumption was strongly associated with self-reported alcohol consumption. 204
A one SD increase in the PRS was associated with an 11.2 g (= 0.93 drinks á 12g) increase in weekly 205 pure alcohol intake (beta=11.2 [9.85-12.6 g], p = 2.3*10 -58 ) (Fig 1, cohort- In the cohorts where alcohol consumption estimates and other related baseline data were available 232 at the cohort entry time, the PRS was associated with an increased risk of incident major alcohol-233 related events and the association was maintained also in the fully adjusted model (n = 28,639, 234 cases = 911). In a meta-analysis of the two cohorts 1 PRS SD was associated with a 26% increased 235 risk of incident alcohol-related events when the consumption-estimate was not in the model 236 We observed a similar increase in the risk of alcohol-related and all-cause mortality. In FinnGen with 244 7,249 deaths one SD increase in the PRS for alcohol consumption was associated with 7 % increase 245 in the risk of death (HR= 1.07 [1.05-1.10], p = 4.3*10 -9 ). The risk estimate between the highest and 246 lowest 20 % in the PRS was 1.23 (HR = 1.23 [1.14-1.23], p = 1.22*10 -8 ). In our prospective cohorts, 247
with cause-of-death information available, 4,125 deaths were recorded ( Table 2) 
DSM-IV Alcohol-use disorder 270
The PRS was also associated with an interview-based DSM-IV alcohol use disorder diagnosis in the 271 We developed a highly polygenic risk score for alcohol consumption by obtaining weights from a 294 recently published large-scale discovery sample and showed that the PRS was strongly associated 295 with alcohol consumption in independent biobank cohort samples. An increased polygenic burden 296 for alcohol consumption was associated with higher incidence of major alcohol-induced health 297 events. The associations remained significant when we accounted for self-reported alcohol 298 consumption and other relevant covariates; in a fully adjusted model the relative risk-estimate 299 between the highest and lowest quintiles of the polygenic risk score was 1.6. Furthermore, the PRS 300 was also associated with both alcohol-related, non-alcohol related and all-cause mortality. 301
302
Comparison with other studies 303 associated with future risk of major alcohol-related health events. While a large number of PRSs 307 have already been established for various traits and diseases (11), the development of PRSs for 308 behavioral traits, such as substance use, has until now been limited (24-27) and the studies have 309 not assessed their impact on future major health events. 310 311 Implications 312
313
Our results show that using a large sample size with long follow-up, we were able to build a PRS of 314 alcohol consumption that is associated not only with alcohol consumption in independent samples, 315 but also with future incident alcohol-related health events. In line with the knowledge that alcohol 316 consumption is a major contributor to the worldwide burden of death, especially among working-317 age adults (1), we found the PRS to be associated also with all-cause mortality, further highlighting 318 the importance of alcohol drinking as a cause of premature death. 319
320
Our score provides a genetic basis for potentially identifying a subset of high-risk individuals even 321 early on in life, with potential for more targeted prevention of AUDs and other alcohol-related 322 morbidity. Prevention is a cost-effective and efficient strategy to reduce alcohol related harms (28) 323
and it is labeled one of the United Nations main health-related worldwide strategies of sustainable 324 development ( https://sustainabledevelopment.un.org/sdg3 ). A higher genetic predisposition for 325 alcohol-related harms was detected both in the presence and absence of alcohol consumption data, 326 as our PRS predicted alcohol-related harms beyond self-reported alcohol consumption. Health 327 services are encouraged to support initiatives for screening and brief interventions for harmful 328 drinking (29) as an effective strategy for tackling alcohol-related harm.(30) Thus, genetic 329 information could potentially be used to improve the arsenal of possible strategies to detect high-330
risk individuals for targets of brief interventions. The fact that individuals in the highest PRS quintile 331 showed an elevated risk for alcohol-related health events even in fully adjusted models could justify 332 the use of genetic information even in clinical settings where a detailed history of alcohol 333 consumption estimates, AUDIT-scores, or similar information are attainable. Communicating the 334 information of higher risk for alcohol-related harm to patients could serve as a motivator for 335 reducing drinking or committing to abstinence. The effect of being aware of one's negative 336 expectations could also be unwanted, as is thought to be the case in the stereotype threat 339 Self-reported alcohol consumption is known to be biased and problematic in terms of reliability and 340 validity for predicting alcohol-related risks (35, 36) . Some bias derives from true measurement error, 341 but another source is the lifelong temporal fluctuation of alcohol-drinking patterns not captured by 342 a measure at one single timepoint. Our PRS was associated with alcohol-related harms even when 343 adjusting for self-reported alcohol consumption estimate. One potential reason for this is that the 344 PRS contains information from the latent genetic predisposition for alcohol consumption, thus 345 overriding both the true measurement error and temporal fluctuations in alcohol drinking volume. 346
347
It has been hypothesized that alcohol consumption-based genetic discovery might inform more 348 about low-level drinking than about problematic drinking and AUDs.(37) However, we built a 349 polygenic risk score for alcohol consumption and successfully used it to predict alcohol-related 350 harms. Due to the robustness of a self-reported single timepoint alcohol consumption estimate and 351 the fact that different alcohol-related traits are to some degree genetically distinct,(9,10) it is 352 expected that a PRS developed directly for alcohol-related morbidity will outperform our PRS in 353 predicting alcohol-related health burden. Supporting this assumption, the general pattern is that 354
PRSs are more strongly associated with their respective diseases than with related phenotypes. 355 (13,14) Unfortunately, no high-quality summary statistics for alcohol-related harms including both 356 somatic and psychiatric outcomes yet exist; the performed GWAS have only covered alcohol 357 dependence (10) and been far smaller in size than our discovery sample of choice, thus making 358 future efforts for large-scale GWAS discovery based on alcohol-related harms more than necessary. 359 360
Strengths and limitations 361 362
Our polygenic risk score was derived using European ancestry discovery samples and tested in the 363 Finnish population. Its applicability in other populations therefore needs further evaluation as the 364 alcohol-related genetic mechanisms may vary between populations. However, it has to be noted 365 that the PRS derived from a non-Finnish sample performed well in the Finnish dataset, even though 366 
